March 12, 2013 — TeraMedica announced the opening of a new U.K. office to service markets in Europe, Africa and the Middle East, spearheading the firm’s international expansion. The company already boasts a significant European installed base achieved through an existing global OEM partnership. It will now drive and support core business directly with regional corporate personnel.
The move follows revenue growth during 2012 for TeraMedica’s Evercore vendor-neutral archive (VNA) technology. The company experienced increased sales across all market segments, from private practice specialty groups to academic centers to government healthcare networks.
Large healthcare systems typically require seamless access to patient images across all access points because of their diversity of clinical services and technologies, and often multiple locations. The VNA’s ability to meet this demand, combined with opportunities for patient analytics enabled by enterprise architecture, make the VNA extremely appealing to university and large hospital environments. To date, nearly a dozen of leading U.S. academic centers have installed the Evercore VNA solution.
Additionally, market drivers such as electronic medical record (EMR) implementation, Stage 2 meaningful use requirements, as well as health information exchanges (HIE), have also helped to fuel double-digit growth for VNA technology.
“Europe represents a large potential market for VNAs, and we wanted to maximize our presence in the area and capitalize on our relationship with our existing distribution partners,” said Eddy Brown, vice president of business development for TeraMedica.
“The new European office will play a pivotal role in our international growth. As a pioneer and leader in vendor neutral archiving, it’s exciting to see market adoption shifting towards the majority. Early adopters have successfully demonstrated the value of an enterprise image archiving solution, and others are now recognizing the benefits and are eager to achieve them,” added Jim Prekop, CEO of TeraMedica.
For more information: www.teramedica.com
February 15, 2024 
